The Experts below are selected from a list of 300 Experts worldwide ranked by ideXlab platform
Patrick D Elliott - One of the best experts on this subject based on the ideXlab platform.
-
validity and utility of the patient health questionnaire phq 2 and phq 9 for screening and Diagnosis of Depression in rural chiapas mexico a cross sectional study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D ElliottAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
-
Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D Elliott, Azucena Espinosa, Andrea Reyes, Eduardo Ortiz-panozo, Elena G Rodriguez-gutierrez, Joia S. MukherjeeAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
Hugo Flores - One of the best experts on this subject based on the ideXlab platform.
-
validity and utility of the patient health questionnaire phq 2 and phq 9 for screening and Diagnosis of Depression in rural chiapas mexico a cross sectional study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D ElliottAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
-
Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D Elliott, Azucena Espinosa, Andrea Reyes, Eduardo Ortiz-panozo, Elena G Rodriguez-gutierrez, Joia S. MukherjeeAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
Jafet Arrieta - One of the best experts on this subject based on the ideXlab platform.
-
validity and utility of the patient health questionnaire phq 2 and phq 9 for screening and Diagnosis of Depression in rural chiapas mexico a cross sectional study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D ElliottAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
-
Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D Elliott, Azucena Espinosa, Andrea Reyes, Eduardo Ortiz-panozo, Elena G Rodriguez-gutierrez, Joia S. MukherjeeAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
Giuseppe Raviola - One of the best experts on this subject based on the ideXlab platform.
-
validity and utility of the patient health questionnaire phq 2 and phq 9 for screening and Diagnosis of Depression in rural chiapas mexico a cross sectional study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D ElliottAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
-
Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
Journal of Clinical Psychology, 2017Co-Authors: Jafet Arrieta, Mercedes Aguerrebere, Giuseppe Raviola, Hugo Flores, Patrick D Elliott, Azucena Espinosa, Andrea Reyes, Eduardo Ortiz-panozo, Elena G Rodriguez-gutierrez, Joia S. MukherjeeAbstract:Background Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and Diagnosis of Depression in primary care settings; however, the validity of their use in rural, Spanish-speaking populations is unknown. Method We used a cross-sectional design to assess the psychometric properties of the PHQ-9 for Depression Diagnosis and estimated the sensitivity and specificity of the PHQ-2 for Depression screening. Data were collected from 223 adults in a rural community of Chiapas, Mexico, using the PHQ-2, the PHQ-9, and the World Health Organization Quality of Life BREF Scale (WHOQOL- BREF). Results Confirmatory factor analysis suggested that the 1-factor structure fit reasonably well. The internal consistency of the PHQ-9 was good (Cronbach's alpha > = 0.8) overall and for subgroups defined by gender, literacy, and age. The PHQ-9 demonstrated good predictive validity: Participants with a PHQ-9 Diagnosis of Depression had lower quality of life scores on the overall WHOQOL-BREF Scale and each of its domains. Using the PHQ-9 results as a gold standard, the optimal PHQ-2 cutoff score for screening of Depression was 3 (sensitivity 80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]). Conclusion The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for Depression screening and Diagnosis in rural, Spanish-speaking populations.
Scott B Patten - One of the best experts on this subject based on the ideXlab platform.
-
The Diagnosis of Depression and its treatment in Canadian primary care practices: an epidemiological study
CMAJ open, 2014Co-Authors: Sabrina T Wong, Donna Manca, David Barber, Rachael Morkem, Shahriar Khan, Jyoti Kotecha, Tyler Williamson, Richard Birtwhistle, Scott B PattenAbstract:About 20 years ago, Anderson and colleagues1 pointed out that individual-level psychological distress, such as Depression, in a population correlates highly with the mean population level of psychological distress.1 Depression has been found to significantly worsen individuals’ overall health status.2 Previous studies report that the prevalence of Depression was significantly higher in patients with heart disease, stroke, diabetes, cancer, rheumatoid arthritis and osteoporosis than in the general population.3,4 It is likely that shared underlying biological mechanisms (e.g., inflammatory processes) are etiological factors in both Depression and other chronic conditions.5,6 The societal burden of Depression includes an estimated cost of US$14 billion in health care expenditures and productivity losses.7 The World Health Organization reports that unipolar depressive disorder is more common than traffic accidents, cerebrovascular disease and ischemic heart disease and therefore responsible for a greater decrease in disability-adjusted life years in middleand high-income countries.7 Depression is so prevalent that it is considered a serious public health issue.2 The 12-month prevalence rate of the most common form of Depression, major depressive disorder, ranges from 5% to 14%.2 A large collaborative study by the World Health Organization, which included 26 000 patients in 15 centres worldwide, found a point prevalence rate of 10.4% for Depression as defined by the International Statistical Classification of Diseases and Related Health Problems, 10th revision.8 It is estimated that, over the course of a single year, 1 360 000 Canadians meet the The Diagnosis of Depression and its treatment in Canadian primary care practices: an epidemiological study
-
the Diagnosis of Depression and its treatment in canadian primary care practices an epidemiological study
CMAJ Open, 2014Co-Authors: Sabrina T Wong, Donna Manca, David Barber, Rachael Morkem, Shahriar Khan, Jyoti Kotecha, Tyler Williamson, Richard Birtwhistle, Scott B PattenAbstract:BACKGROUND: A Diagnosis of Depression is common in primary care practices, but data are lacking on the prevalence in Canadian practices. We describe the prevalence of the Diagnosis among men and women, patient characteristics and drug treatment in patients diagnosed with Depression in the primary care setting in Canada. METHODS: Using electronic medical record data from the Canadian Primary Care Sentinel Surveillance Network, we examined whether the prevalence of a Depression Diagnosis varied by patient characteristics, the number of chronic conditions and the presence of the following chronic conditions: hypertension, diabetes, chronic obstructive pulmonary disease, osteoarthritis, dementia, epilepsy and parkinsonism. We used regression models to examine whether patient characteristics and type of comorbidity were associated with a Depression Diagnosis. RESULTS: of the 304 412 patients who had at least 1 encounter with their primary care provider between Jan. 1, 2011, and Dec. 31, 2012, 14% had a Diagnosis of Depression. Current or past smokers and women with a high body mass index had higher rates of Depression. One in 4 patients with a Diagnosis of Depression also had another chronic condition; those with Depression had 1.5 times more primary care visits. About 85% of patients with Depression were prescribed medication, most frequently selective serotonin reuptake inhibitors, followed by atypical antipsychotics. INTERPRETATION: Our data provide information on the prevalence of a Depression Diagnosis in primary care and associations with being female, having a chronic condition, smoking history and obesity in women. Our findings may inform research and assist primary care providers with early detection and interventions in at-risk patient populations.